AICentralResources
AI Tool Comparison

Comparing as AI Medical Research & Clinical Decision Support
Paige vs DAX Copilot

Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Paige

Paige

VS
DAX Copilot

DAX Copilot

Verdict by Category

AI content generation failed. Refresh the page to try again.
View Paige View DAX Copilot

Detailed Comparison

Feature
Paige
DAX Copilot
Pricing
EnterprisePaige operates exclusively on enterprise contracts with hospital pathology departments, cancer centers, and biopharma companies. There is no published pricing or self-serve option. Clinical deployments are priced based on institution size, scanner ecosystem, patient volume, and AI modules deployed (FullFocus, Paige Prostate, Paige Breast, etc.). Biopharma partnerships are structured as research service agreements for biomarker discovery, companion diagnostic development, and drug trial tissue analysis. Contact Paige through paige.ai to arrange an enterprise discovery call and platform demonstration.
CustomMicrosoft does not publish self-serve pricing for DAX Copilot / Dragon Copilot; access is sold through Microsoft sales or authorized Cloud Solution Provider resellers, and pricing has varied significantly by channel and date. For years, authorized resellers commonly quoted $369-$830+ per provider per month plus a one-time setup fee (often around $650-$700), depending on contract size and minimum term. In a May 2026 marketplace restructuring, Microsoft published tiered list pricing including a Flex plan at roughly $604.80 per user per month (base license plus pay-as-you-go ambient use) and a higher uncapped Per-User tier around $1,512 per user per month (itself a 57% cut from a prior list price). A lower-cost "Physician Practice" license aimed at 5-50 clinician offices was briefly offered via the CSP channel at roughly $150-$160 per user per month before reaching end-of-sale on May 1, 2026. Large health systems negotiating volume, multi-year contracts frequently report effective rates well below these list prices. There is no public free trial for individual purchase, though Microsoft runs structured 30-90 day enterprise pilot programs for qualifying health systems.
Categories
AI Healthcare ToolsAI Research & Education Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
Computational pathology AI from MSK — the first FDA-cleared platform for AI-assisted cancer diagnosis
Microsoft's enterprise ambient AI for physicians, nurses, and radiologists — formerly Nuance DAX
Paige

Paige Pros & Cons

Pros

  • First FDA clearance for AI in primary pathology diagnosis — a historic regulatory milestone
  • First CE mark for AI pathology in Europe — validated for clinical use across EU
  • Founded on MSK's 25M+ pathology slides — the richest cancer pathology training set in the world
  • AIRI infrastructure with 10+ petaFLOPS — enterprise-grade AI compute at clinical scale
  • FullFocus viewer is scanner-neutral with FDA clearances for Leica, Hamamatsu, and Philips
  • The most credentialed AI pathology company in terms of regulatory approvals
  • Backed by Goldman Sachs, Breyer Capital, and Healthcare Venture Partners

Cons

  • Enterprise and institutional access only — not available to small or independent pathology labs
  • No published pricing — all contracts negotiated through enterprise procurement
  • Requires digital pathology infrastructure — scanners, storage, and LIS integration
  • Pathologist review and sign-off still required for all AI-generated results
  • Focused on pathology and oncology — not a general medical imaging platform
DAX Copilot

DAX Copilot Pros & Cons

Pros

  • Broadest role coverage of any major ambient AI platform, spanning physicians, nurses, and radiologists in one product family
  • Deepest, longest-running Epic integration in the category, built on two decades of Dragon speech technology
  • Backed by Microsoft's security, compliance (HITRUST, SOC 2 Type II), and Azure infrastructure at massive scale
  • Extensible via a Developer Kit and third-party app marketplace rather than a closed, single-vendor tool
  • Strong, publicly documented customer outcomes (time-in-note reductions, added appointments) across large health systems
  • Available across multiple countries for physicians, with continued regional expansion

Cons

  • No public pricing; buyers must go through Microsoft sales or a reseller, and quoted rates vary enormously (roughly $150 to $1,500+ per provider per month across sources)
  • No self-serve signup or public free trial, unlike most consumer-facing AI scribes; enterprise procurement is required even for small practices
  • Historically the most expensive mainstream ambient scribe, which prices out solo clinicians and small independent practices
  • EHR write-back connectors for non-Epic systems are sometimes a separate, additional cost arranged through third-party partners
  • Nurse and radiologist experiences have more limited geographic availability (US-only, with radiology still in preview) than the physician product